Multiomics & Biomarkers (CNMB) Morehouse School of Medicine, USA
view profile
José Julio Rodriguez Arellano
IKERBASQUE, Spain
view profile
Illana Gozes
Tel Aviv University, Israel
Kevin K. Wang
Multiomics & Biomarkers (CNMB) Morehouse School of Medicine
USA
Dr. Kevin Wang has been an innovator in CNS therapeutics and theranostic biomarkers, as well as a translational neuroscientist for over 35 years. He previously held leadership positions at Parke-Davis Pharmaceutical and Pfizer Global R&D. two acute TBI blood-based protein biomarkers (UCH-L1/GFAP) that he co-discovered and developed in vitro diagnostic (IVD) tests for have received FDA and EMA regulatory clearance as the first-in-class IVD blood test to aid in the diagnosis of mild TBI patients with brain lesions. These markers together with NFL , Tau and pTau are also gaining momentum for their diagnostic potentials in AD and other neurodegeneration. These TBI blood tests are now on the market under the Abbott i-STAT Anility and bioMérieux VIDAS. Dr. Wang is also a key opinion leader in brain injuries and neurodegeneration. And serve as a subject matter expert for the NIH, the Department of Defense (DOD), and the Veterans Administration (VA) on these topics.
José Julio Rodriguez Arellano
IKERBASQUE
Spain
Over 30 years of research experience in National Centers (Complutense University of Madrid & Institute Cajal –CSIC-) as well as International Centers in Switzerland (Novartis Pharma), France (INSERM), USA (Cornell Medical College & Florida Atlantic University), United Kingdom (The open University & The University of Manchester and Czeck Republic (Institute of Experimental Medicine). Nowadays and from 2009, I work for IKERBASQUE (Basque Foundation for Science, Spain).
Illana Gozes
Tel Aviv University
Israel
Professor Emerita Illana Gozes, formerly, The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, currently, Head, Dr. Diana and Zelman Elton (Elbaum) Laboratory for Molecular Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Faculty of Medical and Health Sciences, Adams Super Center for Brain Studies and Sagol School of Neuroscience, Tel Aviv University, President, European Society for Neurochemistry, Editor-in-Chief, Journal of Molecular Neuroscience, Vice President Drug Development ExoNavis Therapeutics Ltd. B.Sc., Tel Aviv University, Ph.D. Weizmann Institute of Science, Postdoctoral fellowships, MIT and Salk Institute (USA), Sabbaticals, NIH (Fogarty-Scholar-in-Residence) and Humboldt Research Award (Germany). Multiple prizes, papers and patents.
